Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif
- PMID: 10961991
- DOI: 10.1074/jbc.M004293200
Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif
Abstract
Two-hybrid screening in yeast with p73alpha isolated SUMO-1 (small ubiquitin-like modifier 1), the enzyme responsible for its conjugation, Ubc-9, and a number of novel SUMO-1-interacting proteins, including thymine DNA glycosylase, PM-Scl75, PIASx, PKY, and CHD3/ZFH. A subset of these proteins contain a common motif, hhXSXS/Taaa, where h is a hydrophobic amino acid and a is an acidic amino acid, that is shown to interact with SUMO-1 in the two-hybrid system. We show here that p73alpha, but not p73beta, can be covalently modified by SUMO-1. The major SUMO-1-modified residue in p73alpha is the C-terminal lysine (Lys(627)). The sequence surrounding this lysine conforms to a consensus SUMO-1 modification site b(X)XXhKXE, where b is a basic amino acid. SUMO-1-modified p73 is more rapidly degraded by the proteasome than unmodified p73, although SUMO-1 modification is not required for p73 degradation. SUMO-1 modification does not affect the transcriptional activity of p73alpha on an RGC-luciferase reporter gene in SK-N-AS cells. Instead, SUMO-1 modification may alter the subcellular localization of p73, because SUMO-1-modified p73 is preferentially found in detergent-insoluble fractions. Alternatively, it may modulate the interaction of p73 with other proteins that are substrates for SUMO-1 modification or which interact with SUMO-1, such as those identified here.
Similar articles
-
p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.J Biol Chem. 2002 Oct 18;277(42):39769-76. doi: 10.1074/jbc.M204483200. Epub 2002 Aug 6. J Biol Chem. 2002. PMID: 12167641
-
P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.Mol Cancer. 2006 Dec 6;5:68. doi: 10.1186/1476-4598-5-68. Mol Cancer. 2006. PMID: 17150106 Free PMC article.
-
Mdm2 binds p73 alpha without targeting degradation.Oncogene. 1999 Jul 8;18(27):3923-9. doi: 10.1038/sj.onc.1202781. Oncogene. 1999. PMID: 10435614
-
Regulation of p53 family members by the ubiquitin-like SUMO system.DNA Repair (Amst). 2009 Apr 5;8(4):491-8. doi: 10.1016/j.dnarep.2009.01.002. Epub 2009 Feb 12. DNA Repair (Amst). 2009. PMID: 19213614 Review.
-
A potential proteasome-interacting motif within the ubiquitin-like domain of parkin and other proteins.Trends Biochem Sci. 2003 Jun;28(6):280-3. doi: 10.1016/S0968-0004(03)00092-6. Trends Biochem Sci. 2003. PMID: 12826399 Review.
Cited by
-
Identification of Posttranslational Modification-Dependent Protein Interactions Using Yeast Surface Displayed Human Proteome Libraries.Methods Mol Biol. 2015;1319:193-202. doi: 10.1007/978-1-4939-2748-7_10. Methods Mol Biol. 2015. PMID: 26060076 Free PMC article. Review.
-
PML nuclear bodies.Cold Spring Harb Perspect Biol. 2010 May;2(5):a000661. doi: 10.1101/cshperspect.a000661. Epub 2010 Apr 21. Cold Spring Harb Perspect Biol. 2010. PMID: 20452955 Free PMC article. Review.
-
Ubiquitin-dependent degradation of p73 is inhibited by PML.J Exp Med. 2004 Jun 7;199(11):1545-57. doi: 10.1084/jem.20031943. J Exp Med. 2004. PMID: 15184504 Free PMC article.
-
SUMO: a (oxidative) stressed protein.Neuromolecular Med. 2013 Dec;15(4):707-19. doi: 10.1007/s12017-013-8266-6. Epub 2013 Sep 20. Neuromolecular Med. 2013. PMID: 24052421 Review.
-
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71. doi: 10.1038/nrm3011. Nat Rev Mol Cell Biol. 2010. PMID: 21102611 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous